Tango for Alzheimer's Disease Patients' Caregivers

May 2, 2023 updated by: Madeleine Eve Hackney, Emory University

Effects of Adapted Tango on African-American Women Caregivers of Alzheimer's Disease Patients

The goal of the project is to determine the extent to which indices of inflammatory biomarkers, cognition and mood, are influenced by a partnered, dance-based intervention vs control condition in African American (AA) female family caregivers, at high risk for Alzheimer's disease (AD).

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

The importance of informal family caregiving in Alzheimer's disease (AD) is well-established. African-American caregivers are most often middle aged adult children of AD patients (vs. spouses), women, and are at higher risk for chronic health problems. AD lifestyle interventions offer an alternative to medication, and are generally affordable, accessible, and adaptable to the lives of caregivers. To date, most non-pharmaceutical interventions have focused on exercise and nutrition, both of which have proven to be highly successful in conferring AD related benefits and decreasing AD risk.

The goal of the project is to determine the extent to which indices of inflammatory biomarkers, cognition and mood, are influenced by a partnered, dance-based intervention vs control condition in African American (AA) female family caregivers, at high risk for Alzheimer's disease.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Atlanta, Georgia, United States, 30322
        • Atlanta VA Medical Center, Emory University, Executive Park, Wesley Woods

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Women family caregivers from the Emory ADRC and Dr. Wharton's studies of Alzheimer's disease (AD) caregivers
  • Parental diagnosis 'probable AD'
  • African-American
  • 45-65 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adapted Tango Dance
20 improvisational, 90-minute adapted tango dance sessions over a 12-week period.
20 improvisational, 90-minute adapted tango dance sessions over a 12-week period. Classes begin with a 20-minute standing warm-up followed by partnering and rhythmic exercises. Next, novel step elements are introduced and participants will be taught how to combine the new steps with previously learned steps via improvisation. Caregivers will dance with each other or undergraduate /graduate student volunteers. Music will be played throughout classes and artistic expression, i.e., attention to aesthetics, and improvisation, will be encouraged.
Active Comparator: Educational Control
Participants will take part in at least 20 educational lectures offered twice per week over 12 weeks.
Participants will take part in at least 20 educational lectures offered twice per week over 12 weeks. Classes will also be 1.5 hours long and will involve lecture, partnered and group learning and extensive Q&A will be encouraged.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in interleukin-7
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks
Change in interleukin-8
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks
Change in interleukin-9
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks
Change in Interleukin-10
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks
Change in interferon induced protein 10
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks
Change in macrophage derived chemokine
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks
Change in monocyte chemoattractant protein 1
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks
Change in transforming growth factor alpha
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks
Change in tumor necrosis factor alpha
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks
Change in C-reactive protein
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks
Change in serum amyloid protein
Time Frame: Before and after the intervention / control at least 20 times during 12 weeks
45 mL blood will be acquired before and after the intervention to measure the inflammatory and stress marker levels
Before and after the intervention / control at least 20 times during 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Montreal Cognitive Assessment (MoCA)
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
The MoCA test is a 30-point test that assesses several cognitive domains. The short-term memory recall task (5 points) ; Visuospatial abilities are assessed using a clock-drawing task (3 points) and a three-dimensional cube copy (1 point); executive functions are assessed using an alternation task adapted from the trail-making B task (1 point), a phonemic fluency task (1 point), and a two-item verbal abstraction task (2 points). Attention, concentration and working memory are evaluated using a attention task (target detection using tapping; 1 point), a serial subtraction task (3 points), and digits forward and backward (1 point each). Language is assessed using a confrontation naming task with low-familiarity animals (3 points), repetition of two syntactically complex sentences (2 points), and the aforementioned fluency task. Finally, orientation to time and place is evaluated (6 points).
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in the Tower of London test
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
The Tower of London test is used for the assessment of executive functioning specifically to detect deficits in planning. It is related to the classic problem-solving puzzle known as the Tower of Hanoi.The test consists of two boards with pegs and several beads with different colors. The examiner uses the beads and the boards to present the examinee with problem-solving tasks. The performance of the examinee is compared to representative samples of individuals of the same age to derive hypotheses about the person's executive cognitive ability.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in the Stroop interference test
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
The Stroop test is to name the color in which a word is printed, ignoring the word itself. The Stroop Test is used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the imultaneous processing of a second stimulus attribute, well-known as the Stroop Effect. Total time needed for each card is the outcome variable.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in Trails B test
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Trail Test is a neuropsychological test of visual attention and task switching. It consists of two parts in which the subject is instructed to connect a set of 25 dots as quickly as possible while still maintaining accuracy. The time taken to complete the test is used as the primary performance metric.The test is sensitive to detecting cognitive impairment.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in Digit Span test
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
The Digit Span test is either conducted verbally or using a computer program. A sequence of numbers is shown or read out to the participant. The participant is then told to repeat the numbers that were shown or read to them. This process continues until the participant can no longer remember either the full sequence of numbers or the correct order.The Digit Span test is scored by the amount of numbers the participant was able to remember in each test. The scorer must add the total number of correct sequences, backwards and forwards.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in Buschke Selective Reminding Test
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
The Buschke Selective Reminding Test (SRT) is a test designed to measure verbal learning and memory through the use of a list-learning procedure over multiple trials. The adult SRT involves reading the subject a list of 12 unrelated words and then having the subject immediately recall as many of these 12 words as possible. Every trial after the first involves selectively presenting only those words in which the subject did not recall on the immediately preceding trial. The selective reminding trials proceed in this manner until the subject is able to correctly recall all 12 words on three consecutive trials, or until 12 trials have been completed. Scoring of the test has been automated according the instructions of Buschke.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in Reverse Corsi Blocks test
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
The Corsi block-tapping test is a psychological test that assesses visuo-spatial short term working memory. It involves mimicking a researcher as he/she taps a sequence of up to nine identical spatially separated blocks. The sequence starts out simple, usually using two blocks, but becomes more complex until the subject's performance suffers. This number is known as the Corsi Span, and averages about 5 for normal human subjects.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in Brooks spatial memory test
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Brooks spatial memory task (BSMT): In the BSMT, the participant visualizes a 4x4 matrix in which the location of numbers 1 through 8 is described. Participants practice with 3 instructions and progress up to 8 instructions. All levels are completed regardless of errors. Percentages correct (out of 50) will be used for analysis.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in the Body position spatial task (BPST)
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Body position spatial task (BPST) measures whole body knowledge of spatial position and ability to navigate in a remembered path. The examiner verbally and visually demonstrates combinations of 5 possible moves: step forward, step left, step right, quarter turn left, and quarter turn right. The examiner begins with 2 moves and progresses up to 9 moves, with 2 trials per level. Participants continue to the next level if one trial is correctly performed. The test ends when participants miss both trials of a level. Span length and number of correct trials are variables.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in Fullerton Advanced Balance Scale
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
The Fullerton Test is mainly intended to identify highly-active older adults who are at an increased risk to experience fall-related injuries due to sensory impairments. The test uses both dynamic and static balance under different situations to identify balance deficits in older adults. The test includes the following: 10 performance based activities in both static and dynamic phases; Score of 0-40/40 points possible (higher scores are better); tems scored on a 5 point ordinal scale (0-4).
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in 30-second chair stand
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
The 30 second chair test is administered using a folding chair without arms, with seat height of 17 inches (43.2 cm). The 30 second chair stand involves recording the number of stands a person can complete in 30 seconds.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in gait speed
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Assesses walking speed in meters per second over a short duration . The individual is instructed to walk a set distance (6 meters, 10 meters, etc). Time is measured while the individual walks the set distance (often the individual is given space to accelerate to his/her preferred walking speed (this distance is not included when determining speed). The distance covered is divided by the time it took the individual to walk that distance.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in Positive Aspects of Caregiving (PAC) Scale
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
The 9-item PAC scale will be administered to the caregivers. Each item is scored on a 5-point Likert scale: disagree a lot (1), disagree a little (2), neither agree nor disagree (3), agree a little (4), and agree a lot (5). The overall PAC score, comprising all nine items, ranges from 9 to 45-a higher score reflects a more positive perception of the caregiving experience.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in Pearlin Caregiver Stress Scale
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Pearlin Caregiver Stress Scale topics include primary stressors (cognitive status, problematic behavior, overload, relational deprivation), secondary role strains family conflict, job-caregiving conflict, economic strains), secondary instrapsychic strains (role captivity, loss of self, caregiving competence, personal gain) and mediators (management of situation, management of meaning, management of distress, expressive support). Fifteen 3-point to 5-point scales.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in the Zarit Burden Interview
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
The Zarit Burden Interview, a caregiver self-report measure is a 22-item self-report inventory that examines burden associated with functional/behavioral impairments and the home care situation. Each question is scored on a 5 point Likert scale ranging from 0 (Never) to 4 (Nearly Always).. Total scores range from 0 (low burden) to 88 (high burden).
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in the Center for Epidemiologic Studies Depression Scale (CES-D)
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks

The CESD-R is a screening test for depression and depressive disorder. The 20 items in CESDR scale measure symptoms of depression in nine different groups as defined by the American Psychiatric Association. The response values for each question are:

Not at all or less than one day = 0 1-2 days = 1 3-4 days = 2 5-7 days = 3 Nearly every day for 2 weeks = 4 The Total CESD-R Score is calculated as a sum of responses to all 20 questions.

Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
Change in DEMQOL: Dementia Quality of Life measure (Carer v4)
Time Frame: Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks
DEMQOL is a 29-item scale, plus one global item ("Overall, how would you rate your quality of life?") that measures 5 domains of QOL: Positive Affect (6 items), Negative Affect (11 items), Feelings of Belonging (3 items), Self-esteem (4 items), and Sense of Aesthetics (5 items). The DQoL yields scores on 5 subscales but subscale scores are not summed to reach an overall or global measure of QOL.
Before and after the intervention / control, offered twice per week, at least 20 times during 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Madeleine Hackney, School Of Medicine, Emory University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 19, 2017

Primary Completion (Anticipated)

December 1, 2024

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

August 30, 2017

First Submitted That Met QC Criteria

August 30, 2017

First Posted (Actual)

August 31, 2017

Study Record Updates

Last Update Posted (Estimate)

May 4, 2023

Last Update Submitted That Met QC Criteria

May 2, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alzheimer's Disease

Clinical Trials on Adapted Tango Dance

3
Subscribe